Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Website Tools

collage of malaria research images
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Malaria Research Program

The mission of the Division of Intramural Research (DIR) Malaria Research Program (MRP) is to seek fundamental knowledge about the interactions of malaria parasites with the human host and the mosquito vectors that transmit them and to apply this knowledge to prevent disease, enhance health, and improve the quality of life in malaria endemic areas.


Program Overview

photo of an African family 

Mission and Goals

The mission of the DIR Malaria Research Program is to seek fundamental knowledge about the interactions of malaria parasites with the human host and the mosquito vectors that transmit them and to apply this knowledge to prevent disease, enhance health, and improve the quality of life in malaria endemic areas.

photo of a mosquito 


The DIR MRP includes the joint interests of three participating autonomous NIAID DIR Laboratories the Laboratory of Malaria and Vector Research (LMVR), the Laboratory of Malaria Immunology and Vaccinology (LMIV), and the Laboratory of Immunogenetics (LIG). The Chiefs of these three participating Laboratories constitute the Executive Committee (EC). The MRP Director, working with the EC, will be responsible for programmatic and operative activities.

photo of cells 


MRP investigators explore the biology of malaria from the perspective of the human host, the Plasmodium parasite, and the mosquito vector and the interactions among them.

photo of malaria researchers in a lab 

Collaborative Research Fellowship

Fellowships will be awarded annually to a limited number of top applicants who aspire to improve our understanding of the biology, host-pathogen interactions, and transmission of malaria parasites.


Basic Research Goals

  • Explore the acquisition and maintenance of immunity to Plasmodium parasites during natural and experimental malaria infections in humans and experimental models.
  • Understand how Plasmodium parasites cause disease and identify parasite and host factors that determine disease outcome.
  • Investigate the physiology of Plasmodium parasites, including nutrient uptake and erythrocyte invasion, and identify mechanisms of resistance to antimalarial drugs.
  • Understand the interactions between the Plasmodium parasites and mosquito vectors that drive malaria transmission.

Translational Research Goals

This fundamental knowledge would be the basis to develop new malaria control strategies such as the following:

  • Vaccines to prevent the blood stage of the disease and adjunctive therapies for severe disease. While we continue to seek full eradication of malaria, the development of effective blood-stage vaccines and adjunctive therapies for severe disease would save the lives of countless children and pregnant women around the world and thus be a priority for research.
  • A vaccine to interrupt malaria transmission. To block the cycle of malaria transmission, vaccines are needed that prevent liver-stage infections and/or block the ability of the gametocytes to be transmitted or to develop in the mosquito.
  • Measures to reduce the effectiveness of the mosquito vector. Anopheles gambiae and Anopheles funestus complexes, the prevailing mosquitoes in Africa, are “super vectors” for malaria, having a long life span, feeding primarily on humans, and being highly susceptible to infection. To eradicate malaria, methods will need to be developed to modify mosquitoes so that they no longer transmit malaria and to introduce these modified mosquitoes into the field, in Africa and other endemic regions.
  • Effective antimalarial drugs that treat the blood stage of the disease and interrupt transmission. Several such drugs are in various phases of discovery and development, but drug resistance always develops, and new drugs will be needed to control malaria prior to elimination. Drugs are also needed to kill Plasmodium vivax in the liver, preventing relapses. Developing such drugs will likely require understanding the dormant liver phase of the parasite.
  • Rapid diagnostic tests that can quickly detect malaria cases and parasite carriers in human populations. New and improved rapid diagnostic tests will be needed that detect and direct appropriate use of treatments for malaria parasites versus other infectious causes of febrile illness. These tests will be particularly important where malaria control programs reduce the prevalence of infections to low levels prior to eradication.



Executive Committee

photo of Carolina Barillas-Mury

Dr. Carolina Barillas-Mury
Chief, Mosquito Immunity and Vector Competence Section, Laboratory of Malaria and Vector Research (LMVR)


Plasmodium Biology

photo of Thomas Wellems

Thomas Wellems
Malaria Genetics Section

photo of Sanjay Desai

Sanjay Desai
Apicomplexan Molecular Physiology Section

photo of Louis Miller

Louis Miller
Malaria Cell Biology Section

photo of Xin-Zhuan Su

Xin-Zhuan Su
Malaria Functional Genomics Section

Malaria Immunity and Pathogenesis

photo of Patrick Duffy

Patrick Duffy
Pathogenesis and Immunity Section

photo of Michal Fried

Michal Fried
Molecular Pathogenesis and Biomarkers Section

photo of Susan Pierce

Susan Pierce
Lymphocyte Activation Section

photo of Peter Crompton

Peter Crompton
Malaria Infection Biology and Immunity Unit

photo of Rick Fairhurst

Rick Fairhurst
Malaria Pathogenesis and Human Immunity Unit

photo of Tian Jin

Tian Jin
Chemotaxis Signal Section

photo of Eric Long

Eric Long
Molecular and Cellular Immunology Section

photo of Silvia Bolland

Silvia Bolland
Autoimmunity and Functional Genomics Section

Malaria Transmission

photo of Carole Long

Carole Long
Malaria Immunology Section

photo of Carolina Barillas-Mury

Carolina Barillas-Mury
Mosquito Immunity and Vector Competence Section

Collaborative Fellowship

photo of a woman in a lab 

To meet the greatest challenges in malaria research, contemporary studies often rely on collaborative efforts between individual investigators with expertise in different areas. NIAID scientists who study malaria in three separate laboratories have come together to form the Malaria Research Program (MRP) and promote collaborative environments and facilitate next-level breakthroughs in malaria research. The goal of the MRP is to create, strengthen, and sustain interactions within MRP and with other NIH-based investigators who are using diverse yet complementary approaches to tackle the global malaria problem.

The MRP Collaborative Research Fellowship will be awarded annually to a limited number of top applicants who aspire to improve our understanding of the biology, host-pathogen interactions, and transmission of malaria parasites. MRP fellows are expected to play a central role in initiating and maintaining close, balanced, and productive collaborations between two laboratories in the MRP or between the MRP and another NIH-based research program. To help successful applicants gain the knowledge base and skills necessary to launch their own scientific careers, the MRP Collaborative Research Fellowship will provide them the opportunities to do the following:

  • Conduct independent, cutting-edge research at NIH and the NIH Clinical Center in the United States and at NIH-sponsored field sites in several of the world’s malaria-endemic countries
  • Collaborate with other MRP and NIH scientists to make cross-bridging breakthroughs and gain expertise in diverse, complementary areas of science
  • Access the outstanding research experience, resources, and facilities at NIH and at NIAID’s International Centers for Excellence in Research (ICERs) in Mali, Uganda, and India, as well as newly renovated laboratories in Cambodia and Thailand
  • Interact with outstanding MRP and other NIH fellows to form long-lasting personal and scientific relationships
  • Receive mentoring from two or more NIH scientists, including experts in parasite biology and transmission and antimalarial immunity, vaccines, and chemotherapy
  • Attend year-round weekly seminars given by distinguished intramural and extramural investigators from diverse scientific fields
  • Develop public speaking and other communication skills through participation in MRP-wide weekly seminars, journal clubs, and other training activities
  • Develop teaching and mentoring skills through supervision of junior trainees
  • Attend and present research findings at the most relevant, high-quality national and international meetings

NIAID has a decades-long history of making advances in malaria research, including seminal discoveries that significantly improved our understanding of malaria pathogenesis, immunity and vaccinology, human and vector resistance to parasite infection and disease, and parasite resistance to antimalarial drugs.

MRP investigators envision that a more collaborative approach to research will drive the future development of affordable, point-of-care diagnostics for malaria and drug-resistant parasite infections; highly effective drugs that target essential parasite functions and are less vulnerable to acquired drug-resistance mechanisms; vaccines and adjunctive therapies that reduce the morbidity, mortality, and transmission of malaria; and novel strategies that block parasite development in mosquito vectors.

Fellowship Application


Applicants must have a Ph.D., M.D., or equivalent graduate degree awarded within five years of the fellowship start date.


The MRP Collaborative Research Fellowship provides stipend and health insurance for two years, while the primary supervisor and collaborator jointly fund research costs and travel expenses to attend meetings or perform field-based research. The primary supervisor may appoint and fund MRP fellows for an additional two or three years, contingent on the scientific excellence and productivity of the collaboration.

Application Process

The applicant will identify a suitable primary supervisor, who is a current MRP investigator and, together with the primary supervisor, the candidate will define a research project and a suitable collaborator, who is a current MRP or NIH investigator.
Applicants will submit a complete application consisting of the following:

  • The MRP Collaborative Research Fellowship application form (Word), which includes curricular information and a description of the proposed research project
  • Three letters or recommendation, including one from the current advisor​

Promising candidates will be invited to interview with MRP investigators within two months of submitting their application. Interviews will be held at the NIH Twinbrook laboratories in Rockville, MD.


Applications will be accepted throughout the year, and fellowships will be awarded on a rolling admissions schedule. A complete application package should be submitted no later than December 1, 2015, to be considered for the current application cycle. Awardees must begin their appointment no later than September 1, 2016.


Send your application and direct your questions to Dr. Silvia Bolland, Chair, MRP Collaborative Research Fellowship Selection Committee.


Last Updated October 09, 2015